共 50 条
- [31] Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndromeBLOOD ADVANCES, 2020, 4 (04) : 611 - 616Mabrey, Frances LinzeeGardner, Kelda M.Dorcy, Kathleen ShannonPerdue, AndreaSmith, Heather A.Davis, Alicyn M.Hammer, CodyRizzuto, DonelleJones, SunnyQuach, KimScott, Bart L.Hendrie, Paul C.Percival, Mary-Elizabeth M.Walter, Roland B.Appelbaum, Frederick R.Estey, Elihu H.Becker, Pamela S.
- [32] Lenalidomide in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia with Chromosome 5 AbnormalitiesBLOOD, 2009, 114 (22) : 52 - 52Mollgard, LarsNilsson, LarsKjeldsen, LarsDybedal, IngunnDufva, Inge HoghGarelius, HegeNorgaard, Jan MaxwellLinder, OlleEjerblad, ElisabethAstermark, JanHellstrom-Lindberg, Eva
- [33] PARP inhibitors-understanding the risk of myelodysplastic syndrome and acute myeloid leukaemiaLANCET HAEMATOLOGY, 2021, 8 (02): : e97 - e99Tinker, Anna, V
- [34] Molecular mechanisms of the progression of myelodysplastic syndrome to secondary acute myeloid leukaemia and implication for therapyANNALS OF MEDICINE, 2015, 47 (03) : 209 - 217Dan, ChunliChi, JianxiangWang, Li
- [35] Models to study myelodysplastic syndrome and acute myeloid leukaemiaCURRENT OPINION IN HEMATOLOGY, 2025, 32 (02) : 87 - 92Chao, CliffordMartinez, Isabella G.Wagenblast, Elvin
- [36] Busulfan-based myeloablative conditioning regimens for haploidentical transplantation in high-risk acute leukemias and myelodysplastic syndromesEUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (03) : 332 - 339Gayoso, JorgeBalsalobre, PascualKwon, MiHerrera, PilarBermudez, AranchaSampol, AntoniaJimenez, SantiagoLopez-Corral, LuciaSerrano, DavidLuis Pinana, JosePascual, Maria J.Heras, InmaculadaBento, LeyreVarela, RosarioHumala, KaremZabalza, AmayaLaiglesia, AlmudenaBastos-Oreiro, MarianaPerez-Corral, AnaMartinez-Laperche, CarolinaBuno, IsmaelDiez-Martin, Jose L.
- [37] Allogeneic HSCT with reduced intensity conditioning regimens in high risk patients with myelofibrosisBIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 12 - 12Rondelli, DBarosi, GBacigalupo, APrchal, JTPopat, UAlessandrino, EPSpivak, JLHoffman, RFruchtman, S
- [38] Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndromeHAEMATOLOGICA, 2017, 102 (10) : 1709 - 1717Daver, NavalKantarjian, HagopGarcia-Manero, GuillermoJabbour, EliasBorthakur, GautamBrandt, MarkPierce, SherryVaughan, KennethNing, JingGonzalez, Graciela M. NoguerasPatel, KeyurJorgensen, JefferyPemmaraju, NaveenKadia, TapanKonopleva, MarinaAndreeff, MichaelDiNardo, CourtneyCortes, JorgeWard, ReneeCraig, AdamRavandi, Farhad
- [39] Cladribine, Idarubicin, Cytarabine (araC), and Venetoclax in Treating Patients with Acute Myeloid Leukemia and High-Risk Myelodysplastic SyndromeBLOOD, 2020, 136Reville, Patrick K.Kantarjian, Hagop M.Borthakur, GautamYilmaz, MusaMontalban-Bravo, GuillermoDiNardo, Courtney D.Andreeff, MichaelDaver, NavalJain, NitinKornblau, Steven M.Jabbour, EliasShort, Nicholas J.Alvarado, YesidOhanian, MaroBose, PrithvirajMasarova, LuciaWang, Sa A.Tidwell, Rebecca S. S.Estrov, Zeev E.Garcia-Manero, GuillermoKonopleva, MarinaRavandi, FarhadKadia, Tapan M.